- Home
- MDXG vs CGBD Comparison
MDXG vs CGBD Comparison
Compare MDXG & CGBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDXG
- CGBD
- Stock Information
- Founded
- MDXG 2006
- CGBD 2012
- Country
- MDXG United States
- CGBD United States
- Employees
- MDXG N/A
- CGBD N/A
- Industry
- MDXG Biotechnology: Pharmaceutical Preparations
- CGBD Finance: Consumer Services
- Sector
- MDXG Health Care
- CGBD Finance
- Exchange
- MDXG Nasdaq
- CGBD Nasdaq
- Market Cap
- MDXG 1.0B
- CGBD 1.0B
- IPO Year
- MDXG N/A
- CGBD 2017
- Fundamental
- Price
- MDXG $7.05
- CGBD $13.67
- Analyst Decision
- MDXG Strong Buy
- CGBD Hold
- Analyst Count
- MDXG 3
- CGBD 3
- Target Price
- MDXG $12.00
- CGBD $14.00
- AVG Volume (30 Days)
- MDXG 812.0K
- CGBD 404.4K
- Earning Date
- MDXG 04-30-2025
- CGBD 05-06-2025
- Dividend Yield
- MDXG N/A
- CGBD 12.94%
- EPS Growth
- MDXG N/A
- CGBD N/A
- EPS
- MDXG 0.27
- CGBD 1.31
- Revenue
- MDXG $352,375,000.00
- CGBD $225,447,000.00
- Revenue This Year
- MDXG $9.23
- CGBD $4.34
- Revenue Next Year
- MDXG $11.49
- CGBD $2.48
- P/E Ratio
- MDXG $26.15
- CGBD $10.48
- Revenue Growth
- MDXG 5.34
- CGBD N/A
- 52 Week Low
- MDXG $5.47
- CGBD $13.12
- 52 Week High
- MDXG $10.14
- CGBD $18.74
- Technical
- Relative Strength Index (RSI)
- MDXG 51.34
- CGBD 35.35
- Support Level
- MDXG $6.53
- CGBD $13.32
- Resistance Level
- MDXG $7.07
- CGBD $14.95
- Average True Range (ATR)
- MDXG 0.33
- CGBD 0.40
- MACD
- MDXG 0.10
- CGBD -0.02
- Stochastic Oscillator
- MDXG 68.03
- CGBD 19.13
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
About CGBD Carlyle Secured Lending Inc.
Carlyle Secured Lending Inc is a specialty finance company that is a closed-end, externally managed, non-diversified management investment company. It focuses on providing directly originated, financing solutions across the capital structure, with a focus on senior secured lending to middle-market companies located in the United States. The company's investment objective is to generate current income and capital appreciation through debt investments in U.S. middle-market companies.